America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
New budgeting challenges require flexible thinking. This brief guide offers strategies to adjust your plan while maintaining financial stability.
24,577 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Greg Abel is stepping into Warren Buffett’s shoes with a plan that could redefine Berkshire Hathaway’s approach. This...
Powell will continue to serve on the Federal Reserve Board after his chair term ends next month, steering a measured ...
Ratepayers may be paying more as grid upgrades to support data centers roll out. A PJM-wide assessment estimates roug...
This deep-dive analyzes redwire (rdw) 2026 earnings potential, examining revenue outlook, contracts, and the catalyst...
A new Nasdaq-100 strategy fund began paying weekly Friday distributions, targeting a 40% yield and challenging the tr...
Losing a partner upends more than your personal life—it can reshape your income too. This guide walks you through the...
Rising financed jewelry debt is reshaping family budgets and investment plans. Experts say debt consolidation seldom ...
Canada's online brokerage scene is evolving as fee cuts and wider cross-border access reshape investor options. Here ...
A high-profile story about cautious texting reveals universal money lessons. This article translates that caution int...
Investors are watching Redwire as its stock keeps rising, driven by backlog gains and contract momentum. This guide b...
Palantir Technologies has had a wild ride. If you’re wondering should palantir technologies stock be bought under $14...